Active Surveillance (AS) for prostate cancer is a management option that continually
monitors early disease and considers intervention if progression occurs. A robust method to …

Objectives To develop a new interface for the widely used prognostic breast cancer tool:
Predict: Breast Cancer. To facilitate decision‐making around post‐surgery breast cancer …

Simple Summary Thymomas and thymic carcinomas (TCs) are malignant thymic epithelial
tumors (TETs) with poor outcome, if non-resectable. Metabolic signatures of TETs have not …

Background Oral squamous cell carcinoma (OSCC) is the dominant histologic type of oral
cancer. Locally advanced OSCC remains a major therapeutic challenge. Our study aimed to …

Abstract Background Predict Prostate is a freely available online personalised risk
communication tool for men with nonmetastatic prostate cancer. Its accuracy has been …

Background An electronic health record–based tool could improve accuracy and eliminate
bias in provider estimation of the risk of death from other causes among men with …

Outcomes from active surveillance have clearly shown that it is the optimal method of
managing many early prostate cancers. Yet, clinician training and healthcare systems are …

Prostate cancer (PC) is the most frequently diagnosed cancer and second leading cause of
cancer-related deaths in men. It is heterogeneous, as is evident from the wide spectrum of …

Background Oral Squamous Cell Carcinoma is the most prevalent malignancies affecting
the oral cavity. Despite progress in studies and treatment options its outlook remains grim …

Background PREDICT Prostate is an endorsed prognostic model that provides
individualised long-term prostate cancer-specific and overall survival estimates. The model …